Endometriosis Medical Therapy
On this page
Direct answer
Every medical option for endometriosis suppresses the disease; none erases it. Hormonal treatment works by inducing a hypo-oestrogenic or progestin-dominated state that starves oestrogen-dependent implants, controlling pain in the majority of women, but lesions persist structurally and symptoms recur after stopping. First-line agents are non-steroidal anti-inflammatory drugs with continuous combined hormonal contraceptives or progestins; second-line options include the levonorgestrel-releasing intrauterine system, GnRH agonists with add-back therapy, and aromatase inhibitors for refractory disease; danazol is now largely historical because of androgenic side effects. None of these agents improve spontaneous fertility, so a woman actively trying to conceive needs surgical or assisted-reproduction pathways rather than prolonged suppression.
What you must remember
- Goal: pain control and suppression, not cure; recurrence of pain within a year or two of stopping treatment is expected and should be discussed upfront.
- First line: NSAIDs (typically mefenamic acid or ibuprofen) plus continuous combined oral contraceptives or a progestin — cheap, effective for dysmenorrhoea and dyspareunia, safe for long cycles.
- Dienogest: progestin specially developed for endometriosis at 2 mg daily, continuously; it decidualises and atrophies implants with a tolerable bleeding profile and years-long usable safety data.
- GnRH agonists: leuprolide or goserelin produce a pseudomenopause; bone mineral density falls, so use is limited to about six months unless paired with add-back hormone therapy (tibolone or low-dose oestrogen-progestin), which protects bone without losing efficacy.
- Danazol: androgenic agent causing acne, hirsutism, voice change and lipid changes; contraindicated in pregnancy — it retains a niche in danazol-loaded vaginal rings and older protocols, but is rarely first choice.
- LNG-IUS (Mirena): reduces dysmenorrhoea and rectovaginal pain and curbs post-surgical recurrence, particularly valuable when heavy bleeding coexists.
- Fertility caution: medical suppression does not raise spontaneous pregnancy rates and delays conception; GnRH agonist pretreatment before IVF is debated but a long protocol remains common practice.
- Refractory pain: aromatase inhibitors such as letrozole, added to a progestin or combined pill, exploit the local aromatase activity of endometriotic tissue — an off-label but exam-worthy strategy.
How to build a treatment sequence
Take a 27-year-old with laparoscopically confirmed stage III endometriosis, crippling dysmenorrhoea and no immediate pregnancy plans. The sequence runs: continuous combined pill or dienogest 2 mg daily with an NSAID during flares — reviewed at three to six months. If pain persists, escalate to the levonorgestrel intrauterine system if bleeding dominates, or to a GnRH agonist with add-back for six months if deep dyspareunia and bowel symptoms dominate. Add-back from the start, not after bone loss, is current teaching. If pain returns after each attempt, repeat laparoscopy with excision — and if ovarian endometriomas exceed about 4 cm, or infertility has become the agenda, surgery precedes further hormones.
The logic to articulate in a viva: choose by dominant symptom (cyclical pain versus deep dyspareunia versus bleeding), by contraceptive need, by bone risk and by fertility intent. The woman trying to conceive now gets surgical excision plus tubal assessment or assisted reproduction; the woman deferring pregnancy gets suppression; the perimenopausal woman gets suppression until natural menopause, since endometriosis usually quiets when oestrogen falls.
Where students slip
Two misconceptions dominate. The first is that medical therapy improves fertility — it does not; suppression merely buys time, and age is the enemy, so do not park a 34-year-old on GnRH agonists for two years. The second is forgetting add-back therapy or assuming it blunts the GnRH agonist effect: randomised data show add-back preserves bone density while maintaining pain relief, so the exam answer is "give it together from the outset". A third trap is diagnosing "treatment failure" too early — NSAIDs alone tried for one cycle prove nothing; each hormonal step needs three to six months before judgement.
Frequently asked questions
Does medical therapy cure endometriosis?
No; it suppresses oestrogen-dependent activity and controls pain, but implants persist structurally and symptoms commonly recur once treatment stops.
Why is add-back hormone therapy given with GnRH agonists?
To counter the hypo-oestrogenic bone loss and vasomotor symptoms; given concurrently it protects bone mineral density without sacrificing pain relief.
What is the role of dienogest in endometriosis?
A 2 mg daily oral progestin designed for continuous use in endometriosis, inducing decidualisation and atrophy of implants with acceptable long-term tolerability.
Why has danazol fallen out of favour?
Dose-dependent androgenic effects — acne, hirsutism, voice deepening, adverse lipid changes — plus teratogenicity, made it intolerable for most women once safer progestins arrived.
Can medical therapy be used while trying to conceive?
No agent raises spontaneous conception rates, so trying-to-conceive women are routed to surgical excision, ovulation induction or assisted reproduction instead of suppression.